Clinicopathological Profile of Head and Neck Cancers in Army Hospital of Nepal

Head and Neck Cancer Clinical Trial

Official title:

Clinicopathological Profile of Head and Neck Cancers in Army Hospital of Nepal - A Retrospective Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06152055
• Other study ID #: 245
• Status: Completed
• Start date: May 1, 2022
• Est. completion date: April 30, 2023

Study information

• Verified date: November 2023
• Source: Tribhuvan University, Nepal
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This is a observational study conducted at the department of Ear ,Nose and Throat -Head and Neck Surgery (ENT-HNS) of Shree Birendra Hospital ,a tertiary health care centre of Nepal. Head and Neck cancers are the sixth most common cancer in the world. Data was collected from the medical records of Head and Neck Cancer patients who underwent treatment between May 2022 to April 2023.The main aim of the study was to know about the common cancers of head and neck region and their distribution according to the site. Also to know the stage of the presentation with treatment modalities in the tertiary health care centre of Nepal.

Description:

This is a retrospective study to know the prevalence of Head and Neck Cancer at the department of ENT- Head and Neck Surgery of Shree Birendra Hospital ,a tertiary health care centre of Nepal .Head and neck cancers are malignant neoplasms that develops in oral cavity, nasal cavities, paranasal sinuses,nasopharynx, oropharynx, hypopharynx, ear, scalp, salivary gland and neck,Data was collected from the medical records of Head and Neck Cancer patients who underwent treatment between May 2022 to April 2023. Data considered of demographic details of age, sex, diagnosis, subsite specific Head and Neck Cancers, treatment modality and histopathology. The data was analyzed using Stastical Package for Social Sciences (SPSS) version 22. Pearson's chi-square test was applied and p value <0.05 was considered statistically significant.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 76
• Est. completion date: April 30, 2023
• Est. primary completion date: April 30, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 17 Years to 84 Years

Eligibility

Inclusion Criteria:

• All histologically proven cases of head and neck region.

Exclusion Criteria:

• Patient's record with incomplete data.

Related Conditions & MeSH terms

• Head and Neck Cancer
• Head and Neck Neoplasms

Locations

Country	Name	City	State
Nepal	Shree Birendra Hospital	Kathmandu

Sponsors (1)

Lead Sponsor	Collaborator
Tribhuvan University, Nepal

Country where clinical trial is conducted

Nepal, 

References & Publications (1)

Chin D, Boyle GM, Porceddu S, Theile DR, Parsons PG, Coman WB. Head and neck cancer: past, present and future. Expert Rev Anticancer Ther. 2006 Jul;6(7):1111-8. doi: 10.1586/14737140.6.7.1111. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Age - wise Distribution of Head and Neck Cancers (HNCs)	Age - wise Distribution of Head and Neck Cancer	1 year
Primary	: Distribution of HNCs according to subsite	Distribution of Head and Neck Cancers according to the subsite	1 year
Primary	Histopathology of HNCs	Histopathology of Head and Neck Cancer	1 year
Primary	Tumor, Nodes, Metastasis (TNM) staging of HNC	Staging at presentation of Head and Neck Cancer	1 year
Primary	Treatment provided to HNC patients	Treatment Modalities of Head and Neck Cancer	1 year